Table 1.

Characteristics of Patients and Physicians

Characteristic	Intervention	Control	P
Patients	N = 218	N = 217
Male, %	77.5	77.0	0.89
Age, y (SD)	61.3 (9.4)	60.1 (9.2)	0.20
Race/ethnicity,%			0.43
White	52.8	48.4
African-American	16.1	14.3
Asian	0.9	1.8
Hispanic	4.6	3.7
Other	10.6	9.2
Unknown	15.1	22.6
Framingham risk score, % (SD)	14.2 (6.7)	13.8 (6.3)	0.49
Global cardiovascular risk score, % (SD)a	24.4 (11.3)	23.9 (10.6)	0.64
Total cholesterol, mg/dl (SD)	228.1 (32.7)	225.9 (29.4)	0.46
LDL cholesterol, mg/dl (SD)	156.5 (26.4)	156.3 (24.6)	0.92
HDL cholesterol, mg/dl (SD)	44.2 (13.5)	43.5 (12.1)	0.58
Triglycerides, mg/dl (SD)	137.4 (70.2)	132.5 (75.7)	0.49
Systolic blood pressure, mm Hg (SD)	135.2 (16.1)	137.2 (16.6)	0.20
Diastolic blood pressure, mm Hg (SD)	80.8 (10.1)	82.8 (9.1)	0.03
Drug treated hypertension,%	56.0	55.8	0.97
Current smoking,%	14.7	20.3	0.12
Aspirin treated, %	17.4	23.0	0.15
Previously prescribed lipid-lowering drug, %	14.7	13.4	0.69
Physicians	N = 14	N = 15
Male, %	50	40	0.59
Number of eligible patients, median (IQR)	9 (5–20)	6 (4–21)	0.88

HDL high-density lipoprotein; IQR interquartile range; LDL low-density lipoprotein; SD standard deviation

^aThe Global Cardiovascular Risk Score is described in reference 17